Conventional anti- CKD interventions often include sodium-glucose co-transporter 2 (SGLT2) inhibitors and renin-angiotensin system (RAS) inhibitors, which can effectively managing CKD in some patients
(2022, July 21)
The present study (Nicholls et al, 2025) SURPASS-CVOT (Study of Tirzepatide Compared with Dulaglutide on Major Cardiovascular Events in Participants with Type 2 Diabetes) was a double-blind, randomised, active-comparator study to determine non-inferiority of tirzepatide 15 mg (or highest tolerated dose) versus dulaglutide 1.5 mg in terms of 3-point MACE, in people aged 50 years with type 2 diabetes and established CVD
Resumiendo, Mounjaro (Tirzepatida), combina las dos incretinas el GLP-1 y el GIP , las dos hormonas retrasan el vaciamiento gstrico y a nivel del cerebro aumentan la saciedad, disminuyendo la ingesta de alimentos, reduciendo la sensacin de hambre que finalmente lleva a una disminucin de peso principalmente por una disminucin de la masa grasa.
Shoemaker AH, Silver HJ, Buchowski M, Slaughter JC, Yanovski JA, Elfers C, et al
GLP-1 ads are everywhere, and the telehealth market is more crowded and confusing than ever
